PARP inhibitor and androgen receptor inhibitor
This page covers all PARP inhibitor and androgen receptor inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting PARP enzymes and androgen receptor.
Targets
PARP enzymes and androgen receptor
Marketed (1)
- Talazoparib with enzalutamide · Pfizer · Oncology · 2194
Patent intelligence
- parp inhibitor and androgen receptor inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates